Next Article in Journal
Natural Brucella melitensis Infection and Rev. 1 Vaccination Induce Specific Brucella O-Polysaccharide Antibodies Involved in Complement Mediated Brucella Cell Killing
Next Article in Special Issue
Evaluation of the Humoral Immune Response of a Heterologous Vaccination between BBIBP-CorV and BNT162b2 with a Temporal Separation of 7 Months, in Peruvian Healthcare Workers with and without a History of SARS-CoV-2 Infection
Previous Article in Journal
Adverse Events Reporting Quality of Randomized Controlled Trials of COVID-19 Vaccine Using the CONSORT Criteria for Reporting Harms: A Systematic Review
Previous Article in Special Issue
Assessment of the Neutralizing Antibody Response of BNT162b2 and mRNA-1273 SARS-CoV-2 Vaccines in Naïve and Previously Infected Individuals: A Comparative Study
 
 
Article

Article Versions Notes

Vaccines 2022, 10(2), 316; https://doi.org/10.3390/vaccines10020316
Action Date Notes Link
article xml file uploaded 17 February 2022 11:43 CET Original file -
article xml uploaded. 17 February 2022 11:43 CET Update https://www.mdpi.com/2076-393X/10/2/316/xml
article pdf uploaded. 17 February 2022 11:43 CET Version of Record https://www.mdpi.com/2076-393X/10/2/316/pdf
article supplementary file uploaded. 17 February 2022 11:43 CET - https://www.mdpi.com/2076-393X/10/2/316#supplementary
article html file updated 17 February 2022 11:45 CET Original file -
article html file updated 31 July 2022 21:00 CEST Update https://www.mdpi.com/2076-393X/10/2/316/html
Back to TopTop